News - Zhongshan Wanhan Pharmaceuticals Co., Ltd

Join hands with Xipu · Development increment Wanhan Pharmaceutical invites you to visit and negotiate
WANHAN PHARMACEUTICAL COMPANY: Praloflaxin API has been approved.
WANHAN PHARMACEUTICAL COMPANY: Bromfenac Sodium Eye Drops (Preservative-Free and Single-Dose) - 0.4ml/Unit has been officially approved.
WANHAN PHARMACEUTICAL COMPANY: Bromfenac Sodium Eye Drops has been authorized.
WANHAN PHARMACEUTICAL COMPANY: Sodium Hyaluronate Eye Drops (Preservative-Free and Single-Dose) - 0.4ml/Unit has been successfully approved.
WANHAN PHARMACEUTICAL COMPANY: Sodium Hyaluronate Eye Drops - 0.3% (5ml: 15mg) has been formally approved.
WANHAN PHARMACEUTICAL COMPANY: Moxifloxacin Hydrochloride Eye Drops (Preservative-Free and Single-Dose) - 0.4ml/Unit has been officially approved.
WANHAN PHARMACEUTICAL COMPANY: Levofloxacin Eye Drops (Preservative-Free and Single-Dose) - 0.4ml/Unit has been formally approved.

Contact Us

Foreign Trade (API, FDF)

Mob：

+86 139 - 2498 - 2439（WeChat＆WhatsApp）

+86 199 - 2800 - 9162（WhatsApp)

+86 199 - 6631 - 1970（WhatsApp)

E-mail：

Foreign-Trade@whpt.com.cn

Copyright @ 2023: Zhongshan Wanhan Pharmaceutical Co., Ltd.